{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T10:49:52Z","timestamp":1744368592735},"reference-count":15,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.transproceed.2007.06.056","type":"journal-article","created":{"date-parts":[[2007,9,21]],"date-time":"2007-09-21T11:13:29Z","timestamp":1190373209000},"page":"2131-2134","source":"Crossref","is-referenced-by-count":7,"title":["Sirolimus Monotherapy as Maintenance Immunosuppression: Single-Center Experience in 50 Kidney Transplant Patients"],"prefix":"10.1016","volume":"39","author":[{"given":"E.M.","family":"Arellano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Campistol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Oppenheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Diekmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2007.06.056_bib1","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after Kidney transplantation","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.transproceed.2007.06.056_bib2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1399-0012.2006.00529.x","article-title":"New onset diabetes mellitus post-kidney transplantation","volume":"20","author":"Kiberd","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2007.06.056_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/01.tp.0000235527.81917.fe","article-title":"Cardiovascular complications after renal transplantation and their prevention","volume":"82","author":"Ojo","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2007.06.056_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/ajkd.1998.v32.pm9708608","article-title":"Cyclosporine arteriolopathy: effects of drug withdrawal","volume":"32","author":"Franceschini","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2007.06.056_bib5","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/01.tp.0000219703.39149.85","article-title":"Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials","volume":"81","author":"Webster","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2007.06.056_bib6","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1097\/01.tp.0000176479.35275.18","article-title":"Sirolimus monotherapy: feasible immunosuppression for long-term follow-up of kidney transplantation\u2014a pilot experience","volume":"80","author":"Diekmann","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2007.06.056_bib7","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/j.1600-6143.2005.01055.x","article-title":"A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation","volume":"5","author":"Watson","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2007.06.056_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1432-2277.2006.00280.x","article-title":"Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantation","volume":"19","author":"Alexander","year":"2006","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2007.06.056_bib9","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1600-6143.2006.01412.x","article-title":"Sirolimus conversion for patients with posttransplant Kaposi\u2019s sarcoma","volume":"6","author":"Lebbe","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2007.06.056_bib10","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1016\/j.transproceed.2005.10.076","article-title":"Efficacy of conversion to sirolimus in posttransplantation Kaposi\u2019s sarcoma","volume":"37","author":"Gutierrez-Dalmau","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2007.06.056_bib11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1681\/ASN.2005090993","article-title":"Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation","volume":"17","author":"Campistol","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"3 suppl","key":"10.1016\/j.transproceed.2007.06.056_bib12","doi-asserted-by":"crossref","first-page":"151S","DOI":"10.1016\/S0041-1345(03)00241-0","article-title":"Cardiovascular risk factors of Sirolimus compared with cyclosporine: early experience from two randomized trials in renal transplantation","volume":"35","author":"Legendre","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2007.06.056_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2003.09.003","article-title":"Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a P27 Kip1-independent pathway","volume":"172","author":"Castro","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.transproceed.2007.06.056_bib14","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1182\/blood-2004-10-3932","article-title":"Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells","volume":"105","author":"Battaglia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2007.06.056_bib15","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","article-title":"Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients","volume":"15","author":"Battaglia","year":"2006","journal-title":"J Immunol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134507007737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134507007737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:26:37Z","timestamp":1546561597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134507007737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0041134507007737"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2007.06.056","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}